Резолюция I Всероссийского совещания экспертов по VNS-терапии (10 июня 2019 г., Москва)
References
1. Alexopoulos A/V. Pharmacoresistant epilepsy: definition and explantation. Epileptology. 2013;1:138-42.
2. Amar A.P., Apuzzo M.LJ., Liu C.Y. Vagus nerve stimulation therapy alter failed cranial surgery for intractable epilepsy: results from the vagus nerve stimulation n therapy patient outcome registry. Neurosurgery. 2004; 55: 1086-1093.
3. Englot D. J. Chang E. F., Auguste K. I. Vagus nerve stimulation for epilepsy: A meta-analysis of efficacy and predictors of response. Neurosurg Clin N Am. 2011; 22: 443-8.
4. Jeong S.W., Lee S.K., Hong K.S., Kim K.K., Chung C.K., Kim H. Prognostic factors for the surgery for mesial temporal lobe epilepsy: longitudinal analysis. Epilepsia. 2005; 46 (8): 1273-1279.
5. John W Miller. Epilepsy Surgery in the Frontal Lobe: Terra Incognita or New Frontier? Epilepsy Curr. 2007 Jul; 7 (4): 98-99.
6. Kwan P., Arzimanoglou A., Berg A. T., Brodie M. J., Allen Hauser W., Mathern G., Moshé S. L., Perucca E., Wiebe S., French J. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission of the Therapeutic Strategies. Epilepsia. 2010; 51: 1069-77.
7. LivaNova. VNS Therapy Physician’s Manual. December, 2016.
8. Ryvlin P., Rheims S. Epilepsy surgery: eligibility criteria and presurgical evaluation Epilepsy surgery: eligibility criteria and presurgical evaluation. Dialogues Clin Neurosci. 2008 Mar; 10 (1): 91-103.
Review
For citations:
Резолюция I Всероссийского совещания экспертов по VNS-терапии (10 июня 2019 г., Москва). Epilepsy and paroxysmal conditions. 2019;11(3):298-300. (In Russ.)
Views: 400
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
